Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds

Toxicologic Pathology

Volumn 36, Issue 1, 2008, Pages 43-48

  Merisko Liversidge, Elaine M ^a   Liversidge, Gary G ^a  

^a Elan Drug Technologies   (United States)

Author keywords

NanoCrystal Technology; Nanoparticles; poorly water soluble compounds

Indexed keywords

DRUG; DRUG CARRIER; NANOPARTICLE; WATER;

CHEMISTRY; DRUG FORMULATION; HUMAN; METHODOLOGY; NANOTECHNOLOGY; PHARMACEUTICS; REVIEW; SOLUBILITY; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; PRIORITY JOURNAL;

DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 41949100244     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623307310946     Document Type: Article

References (47)

1. Bittner B Mountfield RJ 2002 Intravenous administration of poorly water soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Curr Opin Drug Discovery Dev 5 59 71
2. Boistelle R Astier JP 1988 Crystallization mechanisms in solution J Crystal Growth 90 14 30
3. Davis SS Washington C Illum L Liversidge GG Sternson L Kirsh R 1987 Lipid emulsions as drug delivery systems Ann N Y Acad Sci 507 75 88
4. Douglas SJ Davis SS Illum L 1987 Nanoparticles in drug delivery Crit Rev Ther Drug Carrier Syst 3 233 61
5. Feynman RP 1959 Plenty of room at the bottom Courtesy of the Archives California Institute of Technology www.its.caltech.edu/~feynman/plenty.html
6. Gabizon A Shmeeda H Barenholz Y 2003 Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies Clin Pharmacokinet 42 419 36
7. Hillery AM Florence AT 1996 The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60nm polystyrene particles after oral administration in the rat Int J Pharm 132 123 30
8. Horn D Rieger J 2001 Organic nanoparticles in the aqueous phase-theory, experiment, and use Angew Chem Int Ed 40 4330 61
9. Horter D Dressman JB 2001 Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract Adv Drug Delivery Rev 46 75 87
10. Illum L Davis SS Wilson CG Thomas NW Frier M Hardy JG 1982 Blood clearance and organ disposition of intravenously administered colloidal particles. Effect of particle size, nature and shape Int J Pharm 2 135 6
11. Jani PU Florence AT McCarthy DE 1992 Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat Int J Pharm 84 245 52
12. Jinno J Kamada N Miyake M Yamada K Mukai T Odomi M Toguchi H Liversidge GG Higaki K Kimura T 2006 Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs J Cont Rel 111 56 64
13. Juliano RL 1988 Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions Adv Drug Delivery 2 31 54
14. Kawakami K Yoshikawa T Mororo Y Hayashi T 2002 Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design J Controlled Release 81 65 74
15. Keck CM Muller RH 2006 Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization Eur J Pharm Biopharm 62 3 16
16. Kocbek P Baumgartner S Kristl J 2006 Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly water-soluble drugs Int J Pharm 312 179 86
17. Kraft WK Steiger B Beussink D Quiring JN Fitzgerald N Greenberg MD Waldman SA 2004 The pharmacokinetics of nebulized nanocrystal budesonide in healthy volunteers J Clin Pharmacol 44 67 72
18. Langguth P Hanafy A Frenzel D Grenier P Nhamias A Ohlig T Vergnault G Span-Langguth H 2005 Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound Drug Development & Industry Pharmacy 31 319 21
19. Letchford K Burt H 2007 A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymerosomes Eur J Pharm Biopharm 65 259 69
20. Liedtke S Wissing S Muller RH Mader K 2000 Influence of high pressure homogenization equipment on nanodispersions characteristics Int J Pharm 160 229 37
21. Lipinski CA 2000 Drug-like properties and the causes of poor solubility and poor permeability J Pharm Tox Meth 44 235 49
22. Lipinski C 2002 Poor aqueous solubility: an industry wide problem in drug discovery Am Pharm Rev 5 82 5
23. Lipper RA 1999 E pluribus product Modern Drug Discovery 2 55 60
24. Liu M Frechet JMJ 1999 Designing dendrimers for drug delivery Pharmaceutical Science and Technology Today 2 393 401
25. Liversidge G Cundy K 1995 Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int J Pharm 125 91 7
26. Merisko-Liversidge E Liversidge GG Cooper ER 2004 Nanosizing: a formulation approach for poorly water-soluble compounds Eur J Pharm Sci 18 113 20
27. Merisko-Liversidge E McGurk S Liversidge GG 2004 Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin Pharm Res 21 1545 53
28. Moghimi S Hunter AC Murray JC 2001 Long-circulating and target specific nanoparticles: theory to practice Pharmacol Rev 53 283 318
29. Mouton JW van Peer A de Beule K Vliet V Donnelly JP Soons PA 2006 Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation Antimicrob Agents Chemother 50 1096 102
30. Muller RH Jacobs C Kayser O 2001 Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect in the future Adv Drug Delivery Rev 47 3 19
31. Ng JD Lorber B Witz J Theobald-Dietrich A Kern D Giege R 1996 The crystallization of biological macromolecules from precipitates: evidence for Ostwald ripening J Crystal Growth 168 50 62
32. Noyes AA Whitney WR 1897 The rate of solution of solid substances in their own solutions J Am Chem Soc 19 930 4
33. Ostwald W 1897 Studien uber die bildung und Umwandlung fester Korper Z Phys Chem 22 289
34. Pace S Pace GW Parikh I Mishra A 1999 Novel injectable formulations of insoluble drugs Pharm Tech 23 116 34
35. Papahadjopoulos D 1988 Liposome formation and properties: an evolutionary profile Biochem Soc Trans 16 910 2
36. Peters K Muller RH 1996 Nanosuspensions for oral application of poorly water soluble drugs In Proceeding European Symposium on Formulation of Poorly-available Drugs for Oral Administration APGI Paris 330 3
37. Poste G Kirsh R 1983 Site-specific (targeted) drug delivery in cancer chemotherapy Biotechnology 1 869 78
38. Poste G Papahadjopoulos D Vail WJ 1976 Lipid vesicles as carriers for introducing biologically active materials into cells Methods in Cell Biol 14 33 71
39. Pouton CW 2000 Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems Eur J Pharm Sci 11 93 8
40. Rabinow BE 2004 Nanosuspensions in drug delivery Nat Reviews: Drug Delivery 3 785 96
41. Shah J Wisniecki P Wagner D Shah P 2007 Case study: development of parenteral nanosuspensions: stability, manufacture and performance At 42nd Annual Technology Arden Conference—Best Practices for Parenteral Dosage Forms: Formulation, Process, Development, Package Selection and Manufacturing. AAPS Meetings and Expositions West Point, NY
42. Shott H Gennaro A 1995 Colloidal dispersions Remington: The Science and Practice of Pharmacy 1 252 77 Mack Publishing Company Easton, PA
43. Singh R Pantarotto D Lacerda L Pastorin G Klumpp C Prato M Bianco A Kostarelos K 2006 Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotrac-ers Proc Nat Acad Sci 103 2257 3362
44. Wilding I 2000 Site-specific drug delivery in the gastrointestinal tract Crit Rev Ther Drug Carrier Syst 17 557 620
45. Wisner E Katzberg R Link D Griffey S Drake C Vessey A Johnson D Haley P 1996 Indirect computer tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model Acad Radio1 3 40 8
46. Wolf G Gazelle G McIntire G Bacon E Toner J Cooper E Haley P 1994 Percutaneous computer tomography lypmphography in the rabbit by subcutaneously injected nanoparticles Acad Radiol 1 352 7
47. Wu Y Loper A Landis E Hettrick L Novak L Lynn K Chen C Thompson K Higgins R Batra U Shelukar S Kwei G Storey D 2004 The role of biopharmaceutics in the development of a clinical nanoparticle formulation of Mk-0869: a beagle dog model predicts improved bioavailability and diminished food effect on absorption in human Int J Pharm 285 135 46